Rufu Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
-
- RNA modifications and cancer 8
- Cancer-related gene regulation 4
- Epigenetics and DNA Methylation 4
- Oncology 14
- Pancreatic and Hepatic Oncology Research 12
- Co-authors
- Quanbo Zhou (15 shared papers)Changhao Chen (7 shared papers)Shangyou Zheng (8 shared papers)Qing Lin (9 shared papers)Yuming Luo (4 shared papers)Huilin Ye (6 shared papers)Lusheng Wei (7 shared papers)Zhihua Li (6 shared papers)
- Journals
- Cancer Research (2 papers)Journal of Clinical Investigation (2 papers)Cancer Letters (2 papers)Cell Death and Disease (2 papers)Molecular Cancer (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Rufu Chen
41 papers receiving 1.3k citations
Rufu Chen's Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 476
- Oncology 383
- Molecular Biology 726
- Immunology 186
- Hepatology 37
Countries citing papers authored by Rufu Chen
This map shows the geographic impact of Rufu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rufu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rufu Chen more than expected).
Fields of papers citing papers by Rufu Chen
This network shows the impact of papers produced by Rufu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rufu Chen. The network helps show where Rufu Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Rufu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 296 | |
| 2 | 2018 | 135 | |
| 3 | 2021 | 92 | |
| 4 | 2020 | 79 | |
| 5 | 2021 | 69 | |
| 6 | 2019 | 56 | |
| 7 | 2023 | 52 | |
| 8 | 2022 | 48 | |
| 9 | 2021 | 45 | |
| 10 | 2019 | 43 | |
| 11 | 2023 | 35 | |
| 12 | 2011 | 34 | |
| 13 | 2014 | 32 | |
| 14 | 2010 | 27 | |
| 15 | 2014 | 26 | |
| 16 | 2020 | 25 | |
| 17 | Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma. | 2005 | 25 |
| 18 | Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer Hit paper breakdown → | 2025 | 24 |
| 19 | 2021 | 18 | |
| 20 | 2015 | 17 |
About Rufu Chen
Rufu Chen is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Surgery, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (12 papers), RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (5 papers), Cancer-related gene regulation (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Epigenetics and DNA Methylation (4 papers), Renal cell carcinoma treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Cancer Research (476 citations), Oncology (383 citations), Molecular Biology (726 citations), Immunology (186 citations) and Hepatology (37 citations). Rufu Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Quanbo Zhou, Changhao Chen, Shangyou Zheng, Qing Lin, Yuming Luo, Huilin Ye, Lusheng Wei, Zhihua Li, Yue Zhao and Yao Kong. Their work appears in journals such as Cancer Research, Journal of Clinical Investigation, Cancer Letters, Cell Death and Disease and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.